Abstract Details

Title Do Blood - Brain Barrier Breakdown Serum Markers Have Clinical Significance in Patients with Onconeuronal Antibodies?

Topic Neuro-oncology

Presentation(s) (-)

Poster/Presentation
Number 192

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Slawomir Michalak, PhD	No disclosure on file
Mieczystaw B. Wender, MD, PhD (Polish Academy of Sciences/Clinical & Research Neuro Unit)	No disclosure on file
Harry Chugani, MD (Childrens Hosp of Michigan)	No disclosure on file
	No disclosure on file
Wojciech Kozubski, MD, PhD (University of Medical Sciences in Poznan)	No disclosure on file
	No disclosure on file

��ɫ��